Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation-Reference-Cited by-同舟云学术

Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation

Published:2016-02-03 Issue:18 Volume:7 Page:25113-25124
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jin Yue¹²,Cai Qingsong¹,Shenoy Anitha K.¹,Lim Sangbin³,Zhang Ying¹,Charles Steve¹,Tarrash Miriam¹,Fu Xueqi²,Kamarajugadda Sushama¹,Trevino Jose G.⁴,Tan Ming³,Lu Jianrong¹

Affiliation:

1. Department of Biochemistry and Molecular Biology, UF Health Cancer Center, University of Florida College of Medicine, Gainesville, FL 32610, USA

2. School of Life Sciences, Jilin university, Changchun 130012, China

3. Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA

4. Department of Surgery, UF Health Cancer Center, University of Florida College of Medicine, Gainesville, FL 32610, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action;Future Medicinal Chemistry;2023-12

2. Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity;Cells;2023-05-12

3. The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat;Mitochondrion;2023-05

4. Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities;Oncogene;2023-04-29

5. Phosphorylation of mammalian mitochondrial EF-Tu by Fyn and c-Src kinases;Cellular Signalling;2023-01